5th AIM Global Summit Meeting

16–17 November 2007
Athens, Greece

The 5th AIM Global Summit Meeting was held in Athens, Greece from 16–17 November 2007 and was attended by around 300 clinical delegates from 34 countries worldwide.

The meeting was designed to update delegates on the latest data in nosocomial infections with particular emphasis on the clinical impact of recent trends in the field, novel resistance mechanisms and their impact on current and future clinical practice, new therapies in the treatment of TB and developments in the diagnosis and therapy of pneumonia.

As usual, the meeting consisted of plenary presentations and interactive case study workshops, but it also incorporated two new sessions. The first of these new sessions gave delegates the opportunity of interacting with the AIM core faculty in an ‘Ask the Expert’ forum. Delegates from Mexico, Greece, Venezuela, the UK and Malaysia presented real-life case studies in which they directed questions on the management of the patient to a panel of the core faculty.

The second session was an ‘AIM in Your Area’ poster competition in which delegates had prepared posters describing the AIM programme they had developed in their country or region. It presented an opportunity of not only interacting with other delegates and the core faculty, but also for sharing ideas with other AIM members. A panel of adjudicators made up of the AIM core faculty decided on a winning poster (Venezuela), runner-up (Greece) and third-prize-winning presentations (jointly presented to Portugal, Mexico and India).

The meeting was deemed a great success by both the core faculty who were present and delegates. 91% of delegates said they would attend a similar meeting in the future.

Day 1

New resistance problems in Gram-negative bacteria: Where do we go from here?
Norbert Suttorp, Germany

Do clinical trials provide a guide to using antibiotics in the real world?
Philip S Barie, USA

Sepsis: An evidence-based update
Andrew Shorr, USA

Day 2

Know your enemy: Surveillance and infection control
Robert Masterton, UK

Update on ventilator-associated pneumonia (new!)
Tobias Welte, Germany

Quantitative cultures to diagnose VAP: How much quantitation? (new!)
Marin H Kollef, USA

TB: New trends – new therapies
Giovanni Di Perri, Italy

Gram-positive update: Problem pathogens and emerging therapies
Renato Grinbaum, Brazil

Making de-escalation achievable in clinical practice
Jeffrey Lipman, Australia

AIM in Your Area Posters

Venezuela (Acrobat PDF)

Greece (Acrobat PDF)

Portugal (Acrobat PDF)

Mexico (Acrobat PDF)

India (Acrobat PDF)

Greece (Acrobat PDF)

Malaysia (Acrobat PDF)

Romania (Acrobat PDF)

Russia (Acrobat PDF)

Thailand (Acrobat PDF)

UK Workmat (Acrobat PDF)

UK Stage 4 (Acrobat PDF)